Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Granger

Showing results (21-30 of 133) with videos related to

Pageof 14
Sort By:
Circulation|November 28, 2001
Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trialY Fu, S Goodman, W C Chang, et al.
American Heart Journal|October 20, 1998
Coagulation markers and outcomes in acute coronary syndromesD Ardissino, P A Merlini, P R Eisenberg, et al.
Journal of the American College of Cardiology|December 1, 1995
Treating menstruating women with thrombolytic therapy: insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trialS L Karnash, C B Granger, H D White, et al.
Journal of the American College of Cardiology|August 1, 1997
Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesB S Crenshaw, S R Ward, C B Granger, et al.
Cardiology|June 26, 2001
Platelet function and fibrinolytic agents: two sides of a coin?K P Callahan, A I Malinin, P A Gurbel, et al.
Journal of the American College of Cardiology|April 1, 1985
Rapid ventricular filling in left ventricular hypertrophy: I. Physiologic hypertrophyC B Granger, M K Karimeddini, V E Smith, et al.
The American Journal of Cardiology|March 1, 1994
Intracranial hemorrhage risk and new thrombolytic therapies in acute myocardial infarctionW B Hillegass, J G Jollis, C B Granger, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|March 20, 2001
Clinical, electrocardiographic, and biochemical data for immediate risk stratification in acute coronary syndromesS Savonitto, R Fusco, C B Granger, et al.
American Heart Journal|March 1, 1997
TIMI grade 3 flow and reocclusion after intravenous thrombolytic therapy: a pooled analysisN A Barbagelata, C B Granger, E Oqueli, et al.
Journal of the American College of Cardiology|March 15, 1993
Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupC B Granger, R M Califf, S Young, et al.
Pageof 14

Showing results (21-30 of 133) with videos related to

Sort By:
Pageof 14
Circulation|November 28, 2001
Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trialY Fu, S Goodman, W C Chang, et al.
American Heart Journal|October 20, 1998
Coagulation markers and outcomes in acute coronary syndromesD Ardissino, P A Merlini, P R Eisenberg, et al.
Journal of the American College of Cardiology|December 1, 1995
Treating menstruating women with thrombolytic therapy: insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trialS L Karnash, C B Granger, H D White, et al.
Journal of the American College of Cardiology|August 1, 1997
Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesB S Crenshaw, S R Ward, C B Granger, et al.
Cardiology|June 26, 2001
Platelet function and fibrinolytic agents: two sides of a coin?K P Callahan, A I Malinin, P A Gurbel, et al.
Journal of the American College of Cardiology|April 1, 1985
Rapid ventricular filling in left ventricular hypertrophy: I. Physiologic hypertrophyC B Granger, M K Karimeddini, V E Smith, et al.
The American Journal of Cardiology|March 1, 1994
Intracranial hemorrhage risk and new thrombolytic therapies in acute myocardial infarctionW B Hillegass, J G Jollis, C B Granger, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|March 20, 2001
Clinical, electrocardiographic, and biochemical data for immediate risk stratification in acute coronary syndromesS Savonitto, R Fusco, C B Granger, et al.
American Heart Journal|March 1, 1997
TIMI grade 3 flow and reocclusion after intravenous thrombolytic therapy: a pooled analysisN A Barbagelata, C B Granger, E Oqueli, et al.
Journal of the American College of Cardiology|March 15, 1993
Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupC B Granger, R M Califf, S Young, et al.
Pageof 14